Paxlovid 5 days

DRUG2 trials

Sponsors

ANRS, Emerging Infectious Diseases, Calmy Alexandra

Conditions

COVID-19Immunodeficiency

Phase 2

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

RecruitingNCT05587894

ANRS, Emerging Infectious DiseasesCOVID-19, Immunodeficiency

Start: 2023-04-27End: 2027-06-30Target: 256Updated: 2026-02-23

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients

RecruitingNCT07406217

Calmy AlexandraCOVID-19, Immunodeficiency

Start: 2023-04-27End: 2026-06-30Target: 256Updated: 2026-02-18